Clinical trials in Jaen – page 5

Multiple studies focusing on non-small cell lung cancer and small cell lung cancer treatments, investigating novel combination therapies and targeted approaches for different disease stages.

• EGFR mutation treatments
• Immunotherapy combinations
• Chemotherapy optimization

Research emphasizes improving survival rates through innovative therapeutic approaches for both extensive and limited-stage disease.

Comprehensive research into HER2-positive and hormone receptor-positive breast cancer, exploring new treatment combinations and targeted therapies.

• Endocrine therapy combinations
• Immunotherapy applications
• Targeted molecular treatments

Studies focus on both early-stage and metastatic disease, with emphasis on personalized treatment approaches.

Diverse research covering hepatocellular carcinoma, bladder cancer, and other solid tumors, evaluating novel therapeutic strategies.

• Immunotherapy innovations
• Combination treatment approaches
• Disease-specific therapies

Investigations aim to improve treatment outcomes across multiple cancer types using cutting-edge therapeutic approaches.